Wei-Bin Shen1, Shifa Turan2, Bingbing Wang2, Liviu Cojocaru2, Christopher Harman2, James Logue3, E Albert Reece2,4, Matthew B Frieman3, Peixin Yang2,4. 1. Department of Obstetrics, Gynecology & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA, wbshen@som.umaryland.edu. 2. Department of Obstetrics, Gynecology & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA. 3. Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA. 4. Department of Biochemistry & Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Abstract
INTRODUCTION: Studies indicate a very low rate of SARS-CoV-2 detection in the placenta or occasionally a low rate of vertical transmission in COVID-19 pregnancy. SARS-CoV-2 Delta variant has become a dominant strain over the world and possesses higher infectivity due to mutations in its spike receptor-binding motif. CASE PRESENTATION: To determine whether SARS-CoV-2 Delta variant has increased potential for placenta infection and vertical transmission, we analyzed SARS-CoV-2 infection in the placenta, umbilical cord, and fetal membrane from a case where an unvaccinated mother and her neonate were COVID-19 positive. A 35-year-old primigravida with COVID-19 underwent an emergent cesarean delivery due to placental abruption in the setting of premature rupture of membranes. The neonate tested positive for SARS-CoV-2 within the first 24 h, and then again on days of life 2, 6, 13, and 21. The placenta exhibited intervillositis, increased fibrin deposition, and syncytiotrophoblast necrosis. Sequencing of viral RNA from fixed placental tissue revealed SAR-CoV-2 B.1.167.2 (Delta) variant. Both spike protein and viral RNA were abundantly present in syncytiotrophoblasts, cytotrophoblasts, umbilical cord vascular endothelium, and fetal membranes. CONCLUSION: We report with strong probability the first SARS-CoV-2 Delta variant transplacental transmission. Placental cells exhibited extensive apoptosis, senescence, and ferroptosis after SARS-CoV-2 Delta infection.
INTRODUCTION: Studies indicate a very low rate of SARS-CoV-2 detection in the placenta or occasionally a low rate of vertical transmission in COVID-19 pregnancy. SARS-CoV-2 Delta variant has become a dominant strain over the world and possesses higher infectivity due to mutations in its spike receptor-binding motif. CASE PRESENTATION: To determine whether SARS-CoV-2 Delta variant has increased potential for placenta infection and vertical transmission, we analyzed SARS-CoV-2 infection in the placenta, umbilical cord, and fetal membrane from a case where an unvaccinated mother and her neonate were COVID-19 positive. A 35-year-old primigravida with COVID-19 underwent an emergent cesarean delivery due to placental abruption in the setting of premature rupture of membranes. The neonate tested positive for SARS-CoV-2 within the first 24 h, and then again on days of life 2, 6, 13, and 21. The placenta exhibited intervillositis, increased fibrin deposition, and syncytiotrophoblast necrosis. Sequencing of viral RNA from fixed placental tissue revealed SAR-CoV-2 B.1.167.2 (Delta) variant. Both spike protein and viral RNA were abundantly present in syncytiotrophoblasts, cytotrophoblasts, umbilical cord vascular endothelium, and fetal membranes. CONCLUSION: We report with strong probability the first SARS-CoV-2 Delta variant transplacental transmission. Placental cells exhibited extensive apoptosis, senescence, and ferroptosis after SARS-CoV-2 Delta infection.
Authors: Fulvia Milena Cribiù; Roberta Erra; Lorenza Pugni; Carlota Rubio-Perez; Lidia Alonso; Sara Simonetti; Giorgio Alberto Croci; Garazi Serna; Andrea Ronchi; Carlo Pietrasanta; Giovanna Lunghi; Anna Maria Fagnani; Maria Piñana; Matthias Matter; Alexandar Tzankov; Luigi Terracciano; Andres Anton; Enrico Ferrazzi; Stefano Ferrero; Enrico Iurlaro; Joan Seoane; Paolo Nuciforo Journal: J Clin Invest Date: 2021-03-15 Impact factor: 14.808
Authors: Gabriela N Algarroba; Patricia Rekawek; Sevan A Vahanian; Poonam Khullar; Thomas Palaia; Morgan R Peltier; Martin R Chavez; Anthony M Vintzileos Journal: Am J Obstet Gynecol Date: 2020-05-13 Impact factor: 8.661
Authors: Ling Wang; Juan Zhao; Lam N T Nguyen; James L Adkins; Madison Schank; Sushant Khanal; Lam N Nguyen; Xindi Dang; Dechao Cao; Bal Krishna Chand Thakuri; Zeyuan Lu; Jinyu Zhang; Yi Zhang; Xiao Y Wu; Mohamed El Gazzar; Shunbin Ning; Jonathan P Moorman; Zhi Q Yao Journal: Sci Rep Date: 2021-03-10 Impact factor: 4.379
Authors: Alexander M Kotlyar; Olga Grechukhina; Alice Chen; Shota Popkhadze; Alyssa Grimshaw; Oded Tal; Hugh S Taylor; Reshef Tal Journal: Am J Obstet Gynecol Date: 2020-07-31 Impact factor: 8.661